Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology

Published by: Datamonitor

Published: Apr. 18, 2007 - 10 Pages


Table of Contents


OVERVIEW
CATALYST
SUMMARY
METHODOLOGY
EUROPE IT SPENDING ON BUSINESS INTELLIGENCE SOLUTIONS IN PHARMA
Introduction
Spending by the US and Europe pharmaceutical industry on BI to 2012
Spending by the Big Pharma in Europe on BI to 2012
Spending on BI solutions by US pharmaceutical sub-segments to 2012
Spending by US Big Pharma on BI solutions by technology to 2012
Spending by Global Big Pharma on BI solutions by end-user group to 2012
Spending by Global Biotech on BI solutions by end-user group to 2012
APPENDIX
Definitions
Further reading
Ask the analyst
Datamonitor consulting
Table 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012
Table 2: Spending by the Big Pharma in Europe on BI to 2012
Table 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012
Table 4: Spending by Big Pharma in Europe on BI solutions by technology
Table 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe)
Table 6: Spending by Biotech on BI solutions by end-user group to 2012 (US)
Figure 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012
Figure 2: Spending by the Big Pharma in Europe on BI to 2012
Figure 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012
Figure 4: Spending by Big Pharma in Europe on BI solutions by technology
Figure 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe)
Figure 6: Spending by Biotech on BI solutions by end-user group to 2012 (US)

Abstract

Introduction

Although BI in the earlier stages of drug development remains an emergent solution area in the pharmaceutical market, contextual forces such as pipeline productivity pressures and growing generic competition will drive increased spending on BI in the near future.

Scope

Identifies potential growth areas for technology in Big Pharma in Europe Quantifies spending on BI solutions by pharmaceutical end-user segments Segments IT spending by technology, country and end-user group

Highlights

The adoption of BI solutions will exhibit strong growth over the next five years. The Biotech segment will increase their spending on BI solutions more quickly than Big Pharma BI adoption by clinical end-user groups will demonstrate the most rapid growth compared to R&D, manufacturing and sales & marketing groups.

Reasons to Purchase

Understand the potential opportunity size for BI solutions in the pharmaceutical market. Identify the BI technology areas in which pharmaceutical companies will invest the most heavily. Recognize the differences in BI spending across segments of the market and end-user groups.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008